Specifically, TILs derived from three melanoma patients predominantly expressed LPAR6 with low expression of LPAR2, whereas peripheral CD8+ T cells expressed LPAR6 > LPAR2 > LPAR5 > LPAR4. This evidence concerns the gene LPAR2 and melanoma.